That pattern is often called normal weight obesity, and it is one reason BMI alone misses people who are not obviously overweight but still have poor body composition, low muscle mass, or early metabolic dysfunction
Patients starting Wegovy should expect the most common side effects during dose escalation: nausea (reported in 44% of STEP-1 participants), diarrhea (30%), vomiting (24%), and constipation (24%) [1]
Certificate of Analysis (COA): Available here
For the most up-to-date and accurate information, please refer to the product packaging before use
10.14814/phy2.13852 66 RobertsonR
The extent of changes after stopping also depends on other factors like diet, hydration, sun exposure, and other skincare habits